Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-25-109497
Filing Date
2025-11-12
Accepted
2025-11-12 21:33:07
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 10551
2 FORM OF SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 19, 2025 ea026511701ex-1_qualigen.htm EX-1 246156
3 LEAD INVESTOR AGREEMENT, DATED SEPTEMBER 19, 2025 ea026511701ex-2_qualigen.htm EX-2 48939
4 FORM OF REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 19, 2025 ea026511701ex-3_qualigen.htm EX-3 185616
  Complete submission text file 0001213900-25-109497.txt   493287
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Subject) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-88903 | Film No.: 251475134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 654 MADISON AVENUE, SUITE 1009 NEW YORK NY 10065
Business Address 654 MADISON AVENUE, SUITE 1009 NEW YORK NY 10065 646 502 9845
FARADAY FUTURE INTELLIGENT ELECTRIC INC. (Filed by) CIK: 0001805521 (see all company filings)

EIN.: 844720320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D
SIC: 3711 Motor Vehicles & Passenger Car Bodies
(CF Office: 04 Manufacturing)